• 简

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Davide Campari-Milano (BIT:CPR) Launches Sarti In The US, But Is The Valuation Already Priced In?

    Simply Wall St·09/22/2026 10:22:51
    语音播报

    Davide Campari-Milano (BIT:CPR) just pushed deeper into the U.S. aperitivo scene with the official stateside launch of Sarti, its largest-ever investment behind a single aperitif.

    For investors tracking the bigger picture, Davide Campari-Milano’s €5.96 share price comes with a 90-day share price return of 9.84% and a year-to-date share price return of 8.17%. However, the 3-year total shareholder return has declined 45.04%, which points to improving short-term momentum after a tough multi-year stretch.

    Scan the aperitifs and spirits theme beyond Davide Campari-Milano by comparing it with 615 high quality undiscovered gems that could be riding similar consumption and brand power trends.

    Recent share price gains and the Sarti launch put Davide Campari-Milano back on many watchlists. Is this the moment to pay up for renewed momentum, or does patience for a cheaper entry still make more sense?

    Most Popular Narrative: 34% Undervalued

    Against Davide Campari-Milano’s last close of €5.96, the most followed valuation story points to a fair value of €9.02, using an 8.64% discount rate to frame what the current price implies about execution on growth and margin ambitions.

    While analyst consensus sees cost discipline and efficiency improvements supporting margin expansion, the scale and speed of Campari's SG&A and portfolio streamlining could drive substantially faster EBIT margin accretion and free cash flow generation, particularly as divestments disproportionately shed low-margin brands and SG&A is explicitly guided to drop by 200 basis points over three years.

    See why 0 investors see Davide Campari-Milano as 34% undervalued.

    Result: Fair Value of €9.02 (UNDERVALUED)

    Still, the bullish Davide Campari-Milano story can unravel if health driven shifts curb alcohol demand or if higher tariffs and taxes pressure profits more than expected.

    Find out about the key risks to this Davide Campari-Milano narrative.

    Another Take on Davide Campari-Milano’s Valuation

    The DCF work points to Davide Campari-Milano trading below an estimated fair value, yet the market is asking you to pay 26.5x P/E against a European Beverage average of 17.2x and a fair ratio of 19.1x. That richer multiple narrows the margin for error. Which signal do you trust more right now?

    To test whether this higher P/E leaves enough room for your own assumptions to play out, it helps to unpack the valuation drivers in more detail, then compare them with the broader peer group through our breakdown of relative pricing and earnings power See what the numbers say about this price — find out in our valuation breakdown.

    BIT:CPR P/E Ratio as at Sep 2026
    BIT:CPR P/E Ratio as at Sep 2026

    Next Steps

    Mixed signals around Davide Campari-Milano’s valuation and recent momentum are sparking debate, so consider taking a closer look while sentiment is split and pressure test the full risk and reward picture for yourself with 4 key rewards and 1 important warning sign.

    Looking for more investment ideas beyond Davide Campari-Milano?

    If Davide Campari-Milano has your attention, round out your watchlist with fresh ideas filtered by quality, value, and resilience using the Simply Wall Street Screener.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.